According to the American Association of Clinical Endocrinology (AACE), insulinization should be initiated when therapy, including lifestyle modifications and non-insulin medications, fails to achieve glycemic control goals, or whenever a patient, whether previously exposed to insulin or not, presents symptoms of hyperglycemia. Here, INS is linked to Hyperglycemia.